The ABA Journal is reporting that the ABA has filed a brief urging the U.S. Supreme Court to review a
decision favoring the Federal Trade Commission in its battle to obtain attorney
documents regarding a drug company’s settlement agreement with a generic
manufacturer, arguing that the appellate decision “opens the floodgates” to disclosure of
attorney work product in government investigations. The ABA's
arguments are summarized in a press release available
here. The full brief is available
here.
No comments:
Post a Comment